2ⁿᵈ Edition of the Cancer R&D World Conference 2026 (CRDWC 2026)

Scientific Sessions

Immunomodulatory Molecules in Cancer Therapy

Immunomodulatory molecules are critical in enhancing the immune system's ability to recognize and attack cancer cells. These include immune checkpoint inhibitors, cytokines, and monoclonal antibodies that modulate immune responses. By targeting pathways like PD-1/PD-L1 and CTLA-4, they overcome tumor-induced immune suppression. At the Cancer Research and Development Conference 2025, experts will explore how these therapies revolutionize cancer treatment by boosting immune responses, offering hope for improved outcomes in various malignancies. Advances in this field are driving innovative cancer treatments, providing new avenues for patients and clinicians alike.

Related Sessions

Advances in Nanotechnology for Cancer Treatment
Cellular Therapies Beyond CAR-T
The Role of Epigenetics in Cancer Diagnosis
Cancer Genomics and Epigenomics
Liquid Biopsy Innovations
Immunomodulatory Molecules in Cancer Therapy
Pediatric Oncology
Advances in Cancer Genetics and Genomics
Novel Cancer Vaccines
Systems Biology in Cancer Research
Cutting-Edge Therapies in Cancer Treatment
Tumour Suppressor Molecules in Cancer Therapy
Molecular Imaging Agents for Cancer
Organoids and 3D Bioprinting in Cancer R&D
Telemedicine in Cancer Care
Cancer and Aging
Radiomics and Imaging Biomarkers
Pediatric Oncology Research
Surgical Innovations in Oncology
Cancer Pharmacogenomics
Advances in Radiation Therapy
Cancer Care in the Digital Age
Role of Nutrition in Cancer Care
Breast Cancer
Brain Tumours
Non Small Cell Lung Cancer
Neuroendocrine Cancer
Ovarian Cancer
Cellular Therapies for Cancer
Cancer Research Therapy